Requires NIH to publish a public, searchable listing of NIH‑funded brain tumor biospecimen collections and creates new NIH research programs to accelerate therapies for glioblastoma and brain tumor immunotherapies. Funds a national public awareness campaign about clinical trials and biomarker testing, and establishes a pilot program to improve long‑term care for adult and pediatric brain tumor survivors. The FDA must issue guidance within one year to help people with brain tumors access clinical trials for treatments targeted at other conditions.